Quarter 2018 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2018 Best Performance Since IPO Core EBITDA of $326 million – 49% increase year-on-year Core
, the Company has continually expanded its business by coinvesting with Real Foods (Pty) Ltd., a leader in South Africa’s healthy food market, to operate a healthy food business in Thailand. In terms of
, the Company has continually expanded its business by coinvesting with Real Foods (Pty) Ltd., a leader in South Africa’s healthy food market, to operate a healthy food business in Thailand. In terms of
, the Company has continually expanded its business by coinvesting with Real Foods (Pty) Ltd., a leader in South Africa’s healthy food market, to operate a healthy food business in Thailand. In terms of
(0) 2661-6664 2 INDORAMA VENTURES PUBLIC CO., LTD (SET: “IVL”) MANAGEMENT DISCUSSION AND ANALYSIS (MD&A) FOR THE YEAR ENDED DECEMBER 31, 2017 (CONSOLIDATED) Table 1: Financial Summary - Core Financials
(0) 2661-6664 2 INDORAMA VENTURES PUBLIC CO., LTD (SET: “IVL”) MANAGEMENT DISCUSSION AND ANALYSIS (MD&A) FOR THE YEAR ENDED DECEMBER 31, 2017 (CONSOLIDATED) Table 1: Financial Summary - Core Financials
of KPMG Phoomchai Audit Ltd. as the Company’s Auditor for year 2018. The 2018 audit fee is Baht 1,917,000 excluding other expenses which cover miscellaneous expenses during work period such as
1 (TRANSLATION) SAFARI WORLD PUBLIC COMPANY LIMITED PCL 0107537000351 Ref. No. 080/2019 4 December 2019 Subject: Notification of the Resolution of the Board of Director’s Meeting regarding of the schedule of EGM1/2020, Capital Decrease, Capital increase, an Increasing of investment cost in Carnival Magic Project, and compensation for design and construction to related person. (Update) To: Managing Director The Stock Exchange of Thailand Reference: 1. Information Memorandum on the Issuance and Of...
, 2017 which prior to Board of Director’ Company. The exchange rate is referred to the Bank of Thailand. After the transaction’s completion, CRSB will hold NDR’s ordinary shares for 20.31% of paid
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as